PT Kalbe Farma Tbk.
PTKFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $70,611 | $72,991 | $123,084 | $75,275 |
| - Cash | $4,723 | $3,232 | $3,950 | $6,216 |
| + Debt | $559 | $619 | $1,168 | $626 |
| Enterprise Value | $66,447 | $70,377 | $120,301 | $69,685 |
| Revenue | $32,628 | $30,449 | $28,934 | $26,261 |
| % Growth | 7.2% | 5.2% | 10.2% | – |
| Gross Profit | $12,957 | $11,551 | $11,704 | $11,284 |
| % Margin | 39.7% | 37.9% | 40.5% | 43% |
| EBITDA | $4,614 | $4,433 | $5,246 | $4,874 |
| % Margin | 14.1% | 14.6% | 18.1% | 18.6% |
| Net Income | $3,241 | $2,767 | $3,382 | $3,184 |
| % Margin | 9.9% | 9.1% | 11.7% | 12.1% |
| EPS Diluted | 70.22 | 59.81 | 72.71 | 67.92 |
| % Growth | 17.4% | -17.7% | 7.1% | – |
| Operating Cash Flow | $4,785 | $2,907 | $3,769 | $2,826 |
| Capital Expenditures | -$1,250 | -$1,179 | -$870 | -$1,001 |
| Free Cash Flow | $3,535 | $1,729 | $2,899 | $1,825 |